The significant association between the high DAS-28 CRP scores and having polypharmacy at the 6th month of treatment in the RA group continued at the 12th month of treatment (p = 0.042), while this association was no longer significant for those in the PSA group (p = 0.206). Here, CRP is linked to rheumatoid arthritis.